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Abstract
Patients in critical care lose their capability to make a judgement,
and constitute a ‘vulnerable population’ needing special and
reinforced protection. Even if the standard of informed consent is
an essential way of demonstrating respect for the patient’s
autonomy, the usual informed-consent procedure is not as
applicable as required or sufficient to warrant this ethical principle
in critical care.
Introduction
The evolution of ethics recommendations in medical research
is the result of past history. After each dramatic event that
occurred in the context of medical research, the medical
community and lawyers reacted by editing standards. These
actions allowed defining the conduct that the researchers
must follow in order to ensure the respect for human rights. In
a recent review article, Huang and Hadian report current
controversies regarding ethical standards of research [1].
One of the relevant questions raised about the need for more
standards in ethical research addresses the specific issue of
informed consent in critical care.
The particular critically ill patient
Because of their acute illness and the special environment,
critically ill patients may be temporarily incapacitated. The
critically ill lose their capability to understand and to make a
judgement, and they therefore constitute a ‘vulnerable
population’ needing special and reinforced protection [2].
The participation of critically ill patients in medical research is
particularly important for the community, who will benefit from
the ensuing improvement of care in vital situations. In most
cases this patient does not benefit from their study
participation but endorses the risks. The investigator has the
responsibility to protect the patient and to conduct the study
according to ethical standards. In order to do so, the
investigator should have at their disposal some tools to
distinguish competent and incompetent patients. The
difficulty is that no objective criterion regarding the decision-
making capacity of patients is defined in international and
national directives. Investigators usually use their clinical
judgement and the Glasgow Coma Scale as guidance. If we
had to revise the currently available standards, the definition
of the patients’ capacity should be a priority.
Informed consent in critical care
Informed consent is considered an essential way of protect-
ing the patient and respecting their autonomy. Informed
consent, however, is not sufficient to make a clinical
research ethical. The informed-consent procedure must fulfil
three conditions: adequate information about the study with
a complete disclosure of the risks and benefits, the patient’s
comprehension, and the voluntary nature [3]. Given at the
very beginning of a study, informed consent cannot ensure
the protection of the patient throughout the whole study by
itself. Indeed, we have shown that even when the mandatory
conditions were fulfilled and patients were given a valid
informed consent for a study, most of them were unable to
recall the study components 10 days after the consent
procedure [4,5]. Since the study was ongoing, patients
could not use their right to withdraw from the study at any
time. We suggested that reconsidering the informed-
consent procedure repeatedly during an ongoing study
could be useful in order to respect the patient’s rights. The
ethical role of the investigator does not end at the signature
of the consent document but continues throughout the
whole study.
Until now, no data have analysed the psychological effect of
informed consent in critically ill patients. We could imagine,
however, that the informed consent ‘per se’ could enhance
the anxiety in patients that are already in a stressful
environment and in a critical situation [6,7]. Even if obtaining
informed consent is in most cases an essential way of
demonstrating respect for the patient’s autonomy, it can lead
to some unnecessary and even silly practices [8]. In such
situations, we could question, as did Dreyfuss, whether the
informed consent is not more to protect the investigator than
the patient [9].
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Waiver of consent and estimation of the risk
for critical care research
Because informed consent in emergency research was not
anticipated in previous regulations, the US Food and Drug
Administration recommended in 1996 that research in some
emergency circumstances might be conducted using an
exception from informed consent (that is, a waiver of consent)
[10]. In the study conducted by Annane and colleagues, the
waiver of consent probably contributed to the successful
completion of the study and could allow one to improve
medical knowledge in septic shock [11]. The amendment of
the UK’s Medicines for Human Use Regulations 2004
recently came into force on 12 December 2006. The
regulations now allow, also in the United Kingdom,
unconscious patients in emergency situations to be enrolled
in clinical trials without prior consent provided that this has
been approved by the appropriate ethics committee [12,13].
It is obvious that the risk assessment of the study must be
included when considering a waiving of consent. Weijer
proposed the concept of components analysis according to
therapeutic or nontherapeutic procedures of the research
[14]. This way of evaluating the risks imputable to the
research itself may help institutional review boards to better
balance the potential benefit expected from the study and the
real risks endorsed by the patients. McRae and colleagues
even suggest that the components analysis would facilitate
the approval of emergency research requiring a waiver of
consent while protecting vulnerable research subjects [15].
Conclusions
As suggested by Huang and Hadian, we do not need more
standards but some current standards have to be revisited
because a number of critical care situations were not
anticipated in these standards. Informed consent is a good
example of such a standard procedure that should be
reconsidered. Indeed, the usual informed-consent procedure
is not as applicable as required or sufficient to warrant the
respect of the patient autonomy in the critical care setting.
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